Purpose The benefits of antiviral treatment with remdesivir in hospitalized patients with
COVID-19 remain controversial. Clinical analyses are needed to demonstrate which patient …

Introduction During the early phase of the coronavirus disease 2019 (COVID‐19), remdesivir
was only approved for hospitalized patients. Our institution developed hospital‐based …

Background There is an urgent need to understand the real-world effectiveness of
remdesivir in the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Objectives We performed a systematic review and network meta-analysis of randomized
controlled trials (RCTs) to provide updated information regarding the clinical efficacy of …

Background The use of remdesivir has demonstrated a significant reduction in the time to
recovery in patients with COVID-19. However, the impact on mortality is still controversial …

Background: Remdesivir is recommended for certain hospitalized patients with COVID-19.
However, these recommendations are based on evidence from small randomized trials …

Background There is an urgent need to understand the real-world effectiveness of
remdesivir in the treatment of SARS-CoV-2. Methods This was a retrospective comparative …

To date the optimal antiviral treatment against severe coronavirus disease 2019 (COVID‐19)
has not been proven; remdesivir is a promising drug with in vitro activity against several …

Background: The role of remdesivir in the treatment of patients in hospital with COVID-19
remains ill defined in a global context. The World Health Organization Solidarity randomized …

Purpose This review was aimed to synthesise the best available evidence on the
effectiveness and safety of remdesivir in the treatment of moderate to severe COVID-19 …